Delivery Order SPE2DH25D0001-SPE2D425F660D
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,041.75 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of September 12, 2025. The contract covers CG8+ cartridge products and is structured as a fixed-price delivery order with economic price adjustment provisions. The award was made on September 10, 2025, with no set-aside designation, indicating full and open competition. Performance...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order contract on August 12, 2025, by the Medical Supply Chain, a defense-focused federal agency, for CG8+ Cartridge products. The contract carries a ceiling value of $2,743.75 and is structured as a fixed-price delivery order with economic price adjustment provisions. The performance location is identified as North Chicago, Illinois, which aligns with Abbott's corporate headquarters and reflects the...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,472.50 by the Medical Supply Chain division of the Department of Defense on August 29, 2025, with an ultimate completion date of September 3, 2025. The contract, designated as 4569273740 for a CG8+ Cartridge, utilizes fixed-price pricing with economic price adjustment terms and will be performed in North Chicago, Illinois. This delivery order represents a task order call against a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,130.88 on August 29, 2025, by the Defense Logistics Agency's Medical Supply Chain organization. This fixed-price delivery order with economic price adjustment features a completion date of September 3, 2025, and will be performed at Abbott's facility in North Chicago, Illinois. The contract pertains to cartridge analysis and testing components, consistent with Abbott's core business...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $4,167.00 by the Defense-affiliated Medical Supply Chain agency on August 18, 2025, with an ultimate completion date of August 20, 2025. The contract is for CG8+ cartridges and employs fixed-price pricing with economic price adjustment terms. The work will be performed in North Chicago, Illinois, the location of Abbott's headquarters. This delivery order was awarded without a set-aside...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,247.84 on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract, designated as a Fixed Price with Economic Price Adjustment delivery order, calls for the supply of CG8+ cartridges to support federal healthcare operations. The work will be performed in North Chicago, Illinois, with an ultimate completion date of September 8, 2025. This award was...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,612.00 by the Medical Supply Chain agency (a Defense-affiliated entity) on August 27, 2025, with an ultimate completion date of August 29, 2025. This fixed-price delivery order with economic price adjustment provisions was issued without a set-aside designation, indicating full and open competition. The contract is for cartridge IST CG4+ analysis products, which aligns with Abbott's...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,736.25 by the Defense-affiliated Medical Supply Chain agency on August 25, 2025. The contract, which does not include a set-aside designation, covers the supply of CG8+ cartridges and is classified as a fixed-price delivery order with economic price adjustment provisions. Performance will be completed by August 27, 2025, at Abbott's North Chicago, Illinois facility. This delivery...
- Abbott Laboratories Inc. was awarded a delivery order valued at $1,041.75 by the Medical Supply Chain division of the Department of Defense on July 23, 2025, with an ultimate completion date of July 25, 2025. The contract covers CG8+ cartridge supplies and is structured as a fixed-price agreement with economic price adjustment provisions. Performance will be completed in North Chicago, Illinois, where Abbott maintains its global headquarters. This delivery order was awarded under full and open...
- Abbott Laboratories Inc., operating through its Abbott Point of Care division, was awarded a delivery order on September 10, 2025, for CG8+ cartridge supplies under a fixed-price contract with economic price adjustment provisions. The contract, valued at $1,268.96, is not set aside and represents a full and open competition award. The order is set to be completed by September 12, 2025, with performance taking place at Abbott's facility in North Chicago, Illinois. This delivery order is part of...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D425F660DDelivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, has been awarded a delivery order valued at $2,173.14 by the Medical Supply Chain agency (a Defense component) on September 10, 2025, with a completion date of September 12, 2025. The contract covers CG8+ cartridges and is structured as a fixed-price delivery order with economic price adjustment provisions. The work will be performed in North Chicago, Illinois, where Abbott maintains its headquarters. This award represents a non-competitive delivery order, as no set-aside designation was utilized, indicating it was awarded through full and open competition or as a task order against an existing indefinite delivery vehicle. Abbott Laboratories Inc. is a global healthcare company with an established presence in federal medical procurement, particularly through the Department of Veterans Affairs and Defense Logistics Agency channels. The company specializes in point-of-care diagnostic devices, clinical testing technologies, and medical equipment, with a portfolio that includes immunoassay analyzers, chemistry analyzers, and specialized testing reagents. This delivery order for CG8+ cartridges aligns with the company's core business of providing diagnostic and testing supplies to federal healthcare systems. The relatively modest contract ceiling reflects a focused procurement of a specific cartridge component rather than a broader systems acquisition, consistent with Abbott's role as a supplier of consumable medical diagnostic products to government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/10/25 |